High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- University of Arizona
- Study ID
- NCT03954431
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 40 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Dedicated breast CT(BCT) — DIAGNOSTIC_TESTThe breast CT device will take multiple pictures of the subject's uncompressed breast and creates a 3-D image of the breast.
Study Details
This study is being performed to find out if a new kind of breast imaging (called dedicated breast CT or BCT) can help doctors to see the small structures in breast tissue more clearly. The investigators also want to find out if using the BCT will provide a more accurate diagnosis of breast cancer.
Key Dates
- Start date
- Aug 14, 2025
- Status verified
- Aug 2025
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 600 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Dedicated breast computed tomography (BCT)All subjects will undergo bilateral breast CT (BCT) imaging exam.
Primary Outcome Measure
Diagnostic accuracy [ Time Frame: 12 months after completion of accrual ]
Central Contacts
- Michele Galvan, R.T.R.520-626-2279
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Arizona | Tucson | Arizona | 85724 | Srinivasan Vedantham, PhD (PRINCIPAL_INVESTIGATOR) Alan J-T Chiang, MD, PhD (SUB_INVESTIGATOR) |
Find similar trials in Tucson, AZ
By condition
By specialty
By research site
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPHASE2 · Recruiting · Proton Collaborative Group · Scottsdale, Arizona
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Birmingham, Alabama
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama